» Articles » PMID: 10976635

Mitochondrial Damage in Alzheimer's Disease Varies with Apolipoprotein E Genotype

Overview
Journal Ann Neurol
Specialty Neurology
Date 2000 Sep 8
PMID 10976635
Citations 84
Authors
Affiliations
Soon will be listed here.
Abstract

Brain metabolism and the activity of the alpha-ketoglutarate dehydrogenase complex (KGDHC), a mitochondrial enzyme, are diminished in brains from patients with Alzheimer's disease (AD). In 109 subjects, the Clinical Dementia Rating (CDR) score was highly correlated with brain KGDHC activity. In AD patients who carried the epsilon 4 allele of the apolipoprotein E gene (ApoE4), the CDR score correlated better with KGDHC activity than with the densities of neuritic plaques or neuritic tangles. In contrast, in patients without ApoE4, the CDR score correlated significantly better with tangles and plaques than with KGDHC activity. The results suggest that mitochondrial/oxidative damage may be more important for the cognitive dysfunction in AD patients who carry ApoE4 than in those who do not.

Citing Articles

Mitochondrial Dysfunction Correlates with Brain Amyloid Binding, Memory, and Executive Function in Down Syndrome: Implications for Alzheimer's Disease in Down Syndrome.

Beresford-Webb J, McAllister C, Sleigh A, Walpert M, Holland A, Zaman S Brain Sci. 2025; 15(2).

PMID: 40002463 PMC: 11853603. DOI: 10.3390/brainsci15020130.


New insights in lipid metabolism: potential therapeutic targets for the treatment of Alzheimer's disease.

Cao Y, Zhao L, Chen Z, Li S Front Neurosci. 2024; 18:1430465.

PMID: 39323915 PMC: 11422391. DOI: 10.3389/fnins.2024.1430465.


Apolipoprotein E in Alzheimer's Disease: Focus on Synaptic Function and Therapeutic Strategy.

Qu L, Xu S, Lan Z, Fang S, Xu Y, Zhu X Mol Neurobiol. 2024; 62(3):3040-3052.

PMID: 39214953 DOI: 10.1007/s12035-024-04449-1.


Medium-Chain Triglycerides (MCTs) for the Symptomatic Treatment of Dementia-Related Diseases: A Systematic Review.

Meer N, Fischer T J Nutr Metab. 2024; 2024:9672969.

PMID: 38715705 PMC: 11074881. DOI: 10.1155/2024/9672969.


Discovery of Small Molecule Glycolytic Stimulants for Enhanced ApoE Lipidation in Alzheimer's Disease Cell Model.

Patil S, Kuehn B Pharmaceuticals (Basel). 2024; 17(4).

PMID: 38675451 PMC: 11054693. DOI: 10.3390/ph17040491.